Biotech Stocks

Novo aims to diversify with new pipeline assets and bolt-on deals

Endpoints News 1h ago

Fresh from its rebrand last week, Novo CEO Maziar Mike Doustdar spelled out on Monday the strategic vision that goes along with it. At the Danish drugmaker capital markets day in London ...

Discussion

Sign in to join the discussion. Comments loading…